Allosteric modulation company Addex Therapeutics has entered into a definitive agreement with Armistice Capital, a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 3,752,202 shares in the form of 625,367 American Depositary Shares («ADSs») at
Tags :Frank Gerhard
Oviva, the digital health scaleup provider of diet and lifestyle coaching to people who deal with diet-related health challenges, has raised $80 million in Series C funding to reach millions of people across Europe. The round
Private equity healthcare fund ArchiMed announced the acquisition of Stragen Pharma from its founder and several shareholders, through its EUR 1 billion MED Platform I fund. The advisors Walder Wyss acted as legal counsel
Private equity firm, Naxicap Partners has closed the acquisition of a majority stake in Groupe 3R (Réseau Radiologique Romand), a Swiss radiological network created by Dr. Dominique Fournier. The advisors Python advised Naxicap Partners
The Heubach Group, in partnership with Sk Capital, announced today a definitive agreement to acquire Clariant’s pigments business. The combined business will operate under the Heubach name, creating a global pigments leader generating more
PolyPeptide Group AG, a global operator in peptide development and manufacturing, successfully priced its initial public offering (IPO) at CHF 64 per share, implying a market capitalization of CHF 2.12 bn. The base offering of the IPO
Dufry One launched successfully completed the issuance of CHF 300 m 3.625% Senior Notes due 2026 and EUR 725 m 3.375% Senior Notes due 2028. The Senior Notes are guaranteed by Dufry and certain of its subsidiaries. It is expected that
Nice & Green, an independent Switzerland-based provider of innovative alternative financing solutions for small and mid-sized listed companies headquartered in Nyon, Switzerland, announced a minority growth investment by Artemis Group, owned by Swiss entrepreneur Michael
On March 23, 2021, Dufry One launched, and on March 30, 2021, successfully completed the issuance of CHF 500 million guaranteed senior convertible bonds due 2026 (the 2026 Bonds). The 2026 Bonds are conditionally convertible into ordinary shares of Dufry and are guaranteed
The law firm acted as legal advisor in connection with the global offering of 6,900,000 shares (including shares delivered in the form of American Depositary Shares, or ADSs). The team comprised partner Frank Gerhard (pictured), associates
